Both the latest European guidelines on chronic coronary syndromes and the American guidelines on chest pain have underlined the importance of noninvasive imaging to select patients to be referred to invasive angiography. Nevertheless, although coronary stenosis has long been considered the main determinant of inducible ischemia and symptoms, growing evidence has demonstrated the importance of other underlying mechanisms (e.g., vasospasm, microvascular disease, energetic inefficiency). The search for a pathophysiology-driven treatment of these patients has therefore emerged as an important objective of multimodality imaging, integrating "anatomical" and "functional" information. We here provide an up-to-date guide for the choice and the interpretation of the currently available noninvasive anatomical and/or functional tests, focusing on emerging techniques (e.g., coronary flow velocity reserve, stress-cardiac magnetic resonance, hybrid imaging, functionalcoronary computed tomography angiography, etc.), which could provide deeper pathophysiological insights to refine diagnostic and therapeutic pathways in the next future.

Perspectives in noninvasive imaging for chronic coronary syndromes / D. Morrone, F. Gentile, A. Aimo, M. Cameli, A. Barison, M.E. Picoi, M. Guglielmo, A. Villano, A. Devita, G.E. Mandoli, M.C. Pastore, F. Barillà, M. Mancone, R. Pedrinelli, C. Indolfi, P.P. Filardi, S. Muscoli, I. Tritto, L. Bergamaschi, C. Pizzi, P.G. Camici, M. Marzilli, F. Crea, R.D. Caterina, G. Pontone, D. Neglia, G.A. Lanza. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 365:(2022 Oct 15), pp. 19-29. [10.1016/j.ijcard.2022.07.038]

Perspectives in noninvasive imaging for chronic coronary syndromes

G. Pontone;
2022

Abstract

Both the latest European guidelines on chronic coronary syndromes and the American guidelines on chest pain have underlined the importance of noninvasive imaging to select patients to be referred to invasive angiography. Nevertheless, although coronary stenosis has long been considered the main determinant of inducible ischemia and symptoms, growing evidence has demonstrated the importance of other underlying mechanisms (e.g., vasospasm, microvascular disease, energetic inefficiency). The search for a pathophysiology-driven treatment of these patients has therefore emerged as an important objective of multimodality imaging, integrating "anatomical" and "functional" information. We here provide an up-to-date guide for the choice and the interpretation of the currently available noninvasive anatomical and/or functional tests, focusing on emerging techniques (e.g., coronary flow velocity reserve, stress-cardiac magnetic resonance, hybrid imaging, functionalcoronary computed tomography angiography, etc.), which could provide deeper pathophysiological insights to refine diagnostic and therapeutic pathways in the next future.
CCTA; Cardiac magnetic resonance; Echocardiography; Imaging; Myocardial ischemia; Nuclear imaging;
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
15-ott-2022
ago-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
perspectives.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 4.77 MB
Formato Adobe PDF
4.77 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/954816
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 18
  • OpenAlex 19
social impact